https://www.selleckchem.com/pr....oducts/Temsirolimus.
2020 Forum Multimedia Publishing, LLCBACKGROUND Mortality after cardiac surgery for Ebstein's anomaly ranges from 2.5% to 31%. Independent predictors for mortality and morbidity remain poorly defined because of the low incidence of this congenital anomaly. To identify potentially modifiable factors, this retrospective study investigates the prognostic value of perioperative variables for mortality and morbidity. METHODS We reviewed the charts of 171 patients with Ebstein's anomaly who were at one point in follow-up at our center. O
Like
Comment
Share
